Multiple myeloma is a type of cancer that develops when malignant plasma cells start increasing in the bone marrow. Myeloma is sometimes also called plasma cell cancer and is a type of blood cancers.
Epidemiology:
It is the second most common of these after lymphoma with close to 160,000 new cases diagnosed globally per year. Regardless of the many new treatment modalities being developed for myeloma, it is still a disease that is accompanied by consistent relapses and according to one source, leads to 106,000 deaths per year worldwide.
Myeloma occurs particularly in elderly people; the mean age at diagnosis is 65–70 years. Myeloma is rare in people under the age of 40 years. It is more common in men than in women.
Pathophysiology:
Multiple myeloma (also referred to as myeloma) is a type of rare, incurable cancer of plasma cells. Plasma cells are a type of white blood cell that bone marrow produces. They fight off infection within the body by producing antibodies. Normally, the bone marrow has a small number of plasma cells; however, when plasma cells become cancerous and start multiplying in the bone marrow they lead to disease symptoms
